Biography:
Dr. Borrell is a senior investigator in the Cardiovascular Program at the Hospital de la Santa Creu i Sant Pau, Barcelona. Prior appointments include a postdoctoral position in the Neurology Department of the Curie Institut, Paris, France studying Huntington’s disease. She leads a project based in lipoprotein receptors role in cholesterol metabolism. In recent years she has been developing a project that analyzes the function of PCSK9 beyond its canonical function in cholesterol lowering. These results have been published in different journals including EHJ, BRIC or CVR and lead to the concession of projects financed by both, the government and the industry.
Title : PCSK9’s role in immunomodulation